tiprankstipranks
Lisata Therapeutics malignant glioma treatment granted FDA orphan status
The Fly

Lisata Therapeutics malignant glioma treatment granted FDA orphan status

Lisata Therapeutics’ treatment of malignant glioma was granted orphan designation by the FDA.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on LSTA:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles